Menu
Recruiting NCT03269630

New Orleans Pulmonary Hypertension Biobank

— Observational Pulmonary Hypertension Systemic Sclerosis Mixed Connective Tissue Disease Heart Failure With Normal Ejection Fraction

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: No intervention. Biospecimen collection only.
Who it may be relevant to
Registry conditions: Pulmonary Hypertension, Systemic Sclerosis, Mixed Connective Tissue Disease, Heart Failure With Normal Ejection Fraction. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery pressure \>=25mmHg on right heart catheterization (RHC). Despite advances in PH care, outcomes are still sub-optimal and further research is required into the pathobiology of the disease and development of biomarkers that can guide clinical care. The investigators are establishing a biobank to collect samples (blood, urine, stool) from patients with pulmonary hypertension, patients at high risk for pulmonary hypertension, healthy controls, and patients undergoing right heart catheterization. Specimens will be stored for future investigations.

Interventions

  • Other No intervention. Biospecimen collection only
    Biospecimen collection

Primary outcome measures

  • Collection of biospecimens [Time frame: 10 years]

Eligibility criteria

Inclusion criteria

  • Diagnosis of pulmonary hypertension and followed at the Comprehensive Pulmonary Hypertension Center OR
  • Diagnosis of systemic sclerosis and followed at the Comprehensive Pulmonary Hypertension Center OR
  • Diagnosis of mixed connective tissue disease and followed at the Comprehensive Pulmonary Hypertension Center OR
  • Undergoing outpatient right heart catheterization

Exclusion criteria

  • Age<18
  • Pregnant
  • Unable to understand English
  • Currently incarcerated
  • Unwilling or unable to sign informed consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Other

Study locations

United States · 1 center
  • University Medical Center-New Orleans — New Orleans

Identifiers

NCT: NCT03269630 · LSU

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗